Royal Bank of Canada
OPK icon

Royal Bank of Canada’s Opko Health OPK Stock Holding History

Royal Bank of Canada’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$251K Sell
219,994
-41,026
-16% -$50.5K ﹤0.01% 4568
2025
Q4 		$329K Sell
261,020
-11,846
-4% -$16.5K ﹤0.01% 4466
2025
Q3 		$423K Buy
272,866
+5,418
+2% +$7.44K ﹤0.01% 4609
2025
Q2 		$352K Buy
267,448
+30,839
+13% +$42.2K ﹤0.01% 4731
2025
Q1 		$393K Sell
236,609
-5,319
-2% -$8.76K ﹤0.01% 4165
2024
Q4 		$356K Buy
241,928
+19,873
+9% +$30.4K ﹤0.01% 4348
2024
Q3 		$332K Sell
222,055
-1,118
-0.5% -$1.66K ﹤0.01% 4417
2024
Q2 		$279K Sell
223,173
-39,334
-15% -$51K ﹤0.01% 4487
2024
Q1 		$314K Sell
262,507
-41,904
-14% -$41.9K ﹤0.01% 4312
2023
Q4 		$460K Buy
304,411
+50,248
+20% +$72.6K ﹤0.01% 4339
2023
Q3 		$406K Buy
254,163
+25,738
+11% +$46.9K ﹤0.01% 4221
2023
Q2 		$495K Buy
228,425
+19,358
+9% +$30.3K ﹤0.01% 3961
2023
Q1 		$305K Sell
209,067
-104,288
-33% -$134K ﹤0.01% 4270
2022
Q4 		$392K Buy
313,355
+66,433
+27% +$105K ﹤0.01% 4324
2022
Q3 		$466K Buy
246,922
+56,706
+30% +$134K ﹤0.01% 4093
2022
Q2 		$482K Sell
190,216
-24,773
-12% -$72.2K ﹤0.01% 4122
2022
Q1 		$740K Sell
214,989
-76,816
-26% -$271K ﹤0.01% 3930
2021
Q4 		$1.4M Buy
291,805
+147,106
+102% +$595K ﹤0.01% 3488
2021
Q3 		$528K Buy
144,699
+31,767
+28% +$118K ﹤0.01% 4299
2021
Q2 		$457K Sell
112,932
-35,012
-24% -$137K ﹤0.01% 4363
2021
Q1 		$635K Buy
147,944
+20,654
+16% +$98.7K ﹤0.01% 3973
2020
Q4 		$502K Buy
127,290
+12,600
+11% +$52.6K ﹤0.01% 4137
2020
Q3 		$423K Sell
114,690
-13,412
-10% -$56.6K ﹤0.01% 4010
2020
Q2 		$437K Sell
128,102
-79,661
-38% -$178K ﹤0.01% 3891
2020
Q1 		$277K Buy
207,763
+25,840
+14% +$40.5K ﹤0.01% 4096
2019
Q4 		$268K Buy
181,923
+82,791
+84% +$139K ﹤0.01% 4434
2019
Q3 		$207K Buy
99,132
+700
+0.7% +$1.43K ﹤0.01% 4421
2019
Q2 		$241K Buy
98,432
+223
+0.2% +$487 ﹤0.01% 4363
2019
Q1 		$256K Sell
98,209
-97,758
-50% -$296K ﹤0.01% 4196
2018
Q4 		$589K Buy
195,967
+2,384
+1% +$8.08K ﹤0.01% 3596
2018
Q3 		$670K Buy
193,583
+105,055
+119% +$558K ﹤0.01% 3691
2018
Q2 		$416K Buy
88,528
+1,706
+2% +$6.47K ﹤0.01% 3926
2018
Q1 		$275K Sell
86,822
-31,828
-27% -$128K ﹤0.01% 4119
2017
Q4 		$581K Buy
118,650
+10,421
+10% +$60.5K ﹤0.01% 3683
2017
Q3 		$742K Sell
108,229
-10,520
-9% -$66.3K ﹤0.01% 3481
2017
Q2 		$781K Buy
118,749
+3,739
+3% +$26.2K ﹤0.01% 3290
2017
Q1 		$920K Sell
115,010
-68,166
-37% -$574K ﹤0.01% 3150
2016
Q4 		$1.7M Buy
183,176
+19,032
+12% +$197K ﹤0.01% 2712
2016
Q3 		$1.74M Sell
164,144
-7,621
-4% -$75.9K ﹤0.01% 2653
2016
Q2 		$1.6M Sell
171,765
-96,332
-36% -$978K ﹤0.01% 2727
2016
Q1 		$2.79M Sell
268,097
-209,594
-44% -$1.91M ﹤0.01% 2215
2015
Q4 		$4.8M Sell
477,691
-161,039
-25% -$1.61M ﹤0.01% 1900
2015
Q3 		$5.37M Buy
638,730
+456,815
+251% +$6.05M ﹤0.01% 1544
2015
Q2 		$2.92M Buy
181,915
+43,550
+31% +$677K ﹤0.01% 2005
2015
Q1 		$1.96M Sell
138,365
-25,914
-16% -$337K ﹤0.01% 2294
2014
Q4 		$1.64M Buy
164,279
+29,844
+22% +$255K ﹤0.01% 2492
2014
Q3 		$1.14M Buy
134,435
+19,834
+17% +$174K ﹤0.01% 2746
2014
Q2 		$1.01M Buy
114,601
+5,500
+5% +$48K ﹤0.01% 2823
2014
Q1 		$1.02M Sell
109,101
-9,150
-8% -$80.2K ﹤0.01% 2755
2013
Q4 		$998K Buy
118,251
+1,550
+1% +$15.7K ﹤0.01% 2835
2013
Q3 		$1.03M Sell
116,701
-6,900
-6% -$55.3K ﹤0.01% 2742
2013
Q2 		$878K Buy
+123,601
New +$854K ﹤0.01% 2676

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada's OPK Position: Q1 2026 in Review

Royal Bank of Canada reduced its Opko Health (OPK) stake by 16% in Q1 2026, selling an estimated $50.5K and leaving 219,994 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #4568.

Royal Bank of Canada first reported a position in OPK in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.37M in Q3 2015. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

  • Royal Bank of Canada held 219,994 shares of Opko Health worth $251K as of Q1 2026.
  • Royal Bank of Canada sold 41,026 Opko Health shares in Q1 2026, an estimated $50.5K.
  • Opko Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4568 holding.
  • Royal Bank of Canada first reported a position in Opko Health in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Opko Health position peaked at $5.37M in Q3 2015.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.